Overview
Urapidil has been investigated for the treatment of Hypertension During Pre-Eclampsia.
Indication
用于治疗高血压；尚可用于良性前列腺增生肥大；注射剂主要用于术中高血压危象。
Associated Conditions
- Hypertension
- Hypertensive Emergency
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/10/10 | N/A | Not yet recruiting | Qianfoshan Hospital | ||
2019/01/02 | Phase 3 | Completed | The George Institute for Global Health, China | ||
2018/04/13 | Not Applicable | Completed | Chinese PLA General Hospital | ||
2017/10/03 | Phase 4 | Withdrawn | |||
2016/12/23 | Phase 1 | UNKNOWN | |||
2016/08/05 | Not Applicable | UNKNOWN | Hu Anmin | ||
2015/09/23 | Phase 3 | Terminated | University Hospital, Strasbourg, France | ||
2011/03/09 | Not Applicable | Withdrawn | University Hospital Schleswig-Holstein | ||
2006/12/08 | Phase 3 | UNKNOWN | University Hospital, Strasbourg, France | ||
2005/09/26 | Not Applicable | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| ELGADIL 5 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION | 60241 | SOLUCIÓN INYECTABLE | Uso Hospitalario | Not Commercialized | |
| URAPIDIL ACCORD 5 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG | 76741 | SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN | Uso Hospitalario | Commercialized | |
| URAPIDIL KALCEKS 5 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG | Kalceks As | 85873 | SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN | Uso Hospitalario | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.